A phase I trial of pazopanib (suspension formulation) added to a fixed dose of cetuximab in patients with incurable head and neck squamous cell carcinoma (HNSCC). This is an ASCO Meeting Abstract from ...
Please provide your email address to receive an email when new articles are posted on . DALLAS — Preoperative counseling and perioperative pain management strategies significantly reduced opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results